| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 273.14M | 499.33M | 307.36M | 207.63M | 665.38M |
| Gross Profit | 58.82M | 72.32M | 107.42M | -144.35M | 32.55M |
| EBITDA | -47.69M | -173.16M | -200.14M | -579.48M | -446.66M |
| Net Income | -110.98M | -252.16M | -220.93M | -625.45M | -572.38M |
Balance Sheet | |||||
| Total Assets | 4.24B | 4.42B | 4.44B | 4.27B | 5.13B |
| Cash, Cash Equivalents and Short-Term Investments | 252.17M | 192.02M | 155.80M | 248.50M | 814.81M |
| Total Debt | 1.23B | 1.20B | 548.11M | 192.46M | 418.21M |
| Total Liabilities | 2.55B | 2.62B | 2.34B | 2.04B | 2.58B |
| Stockholders Equity | 1.69B | 1.80B | 2.09B | 2.24B | 2.54B |
Cash Flow | |||||
| Free Cash Flow | 9.55M | -539.18M | -740.66M | -612.77M | -765.96M |
| Operating Cash Flow | 23.34M | -134.09M | -51.48M | -193.96M | -512.72M |
| Investing Cash Flow | 307.82M | -509.04M | -550.56M | -502.64M | -215.74M |
| Financing Cash Flow | -155.60M | 646.76M | 432.01M | 136.56M | 1.31B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | HK$37.99B | 4.66 | 17.22% | 2.96% | 15.36% | 42.66% | |
65 Neutral | HK$795.79B | 35.74 | 16.22% | ― | 25.04% | 71.31% | |
62 Neutral | HK$2.49B | 34.44 | 19.27% | 0.50% | 1.72% | 180.88% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
54 Neutral | HK$260.61M | -22.59 | -11.38% | 8.70% | -16.95% | -461.16% | |
48 Neutral | HK$11.77B | 8.83 | 1.98% | ― | 8.16% | -26.27% | |
46 Neutral | HK$235.67M | -2.82 | -13.04% | ― | -45.30% | 54.30% |